These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 7385835)

  • 1. Kidney stones.
    Kleeman CR; Coburn JW; Brickman AS; Lee DB; Narins RG; Ehrlich RM
    West J Med; 1980 Apr; 132(4):313-32. PubMed ID: 7385835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
    Hess B
    Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
    Pak CY; Sakhaee K; Fuller CJ
    Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of kidney stone composition in the detection of metabolic abnormalities.
    Pak CY; Poindexter JR; Adams-Huet B; Pearle MS
    Am J Med; 2003 Jul; 115(1):26-32. PubMed ID: 12867231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathophysiology, diagnosis and conservative therapy of non-calcium kidney calculi].
    Hochreiter W; Knoll T; Hess B
    Ther Umsch; 2003 Feb; 60(2):89-97. PubMed ID: 12649987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.
    Krieger NS; Asplin JR; Frick KK; Granja I; Culbertson CD; Ng A; Grynpas MD; Bushinsky DA
    J Am Soc Nephrol; 2015 Dec; 26(12):3001-8. PubMed ID: 25855777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Essential arterial hypertension and stone disease.
    Borghi L; Meschi T; Guerra A; Briganti A; Schianchi T; Allegri F; Novarini A
    Kidney Int; 1999 Jun; 55(6):2397-406. PubMed ID: 10354288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of patients with staghorn calculi in our experience.
    Akagashi K; Tanda H; Kato S; Ohnishi S; Nakajima H; Nanbu A; Nitta T; Koroku M; Sato Y; Hanzawa T
    Int J Urol; 2004 May; 11(5):276-81. PubMed ID: 15147542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kidney stones.
    Bushinsky DA
    Adv Intern Med; 2001; 47():219-38. PubMed ID: 11795076
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative study of urinary calcium, oxalate and uric acid in calcium oxalate lithiasis].
    Dumoulin G; Haton D; Wolf JP; Henriet MT; Nguyen NU; Mougin C; Saint-Hillier Y; Combes M; Berthelay S
    Nephrologie; 1984; 5(5):189-91. PubMed ID: 6531054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypocitraturia as a pathogenic risk factor in the mixed (calcium oxalate/uric acid) renal stones.
    Alvarez Arroyo MV; Traba ML; Rapado A
    Urol Int; 1992; 48(3):342-6. PubMed ID: 1589930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic abnormalities associated with calyceal diverticular stones.
    Auge BK; Maloney ME; Mathias BJ; Pietrow PK; Preminger GM
    BJU Int; 2006 May; 97(5):1053-6. PubMed ID: 16643491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and treatment of calcium kidney stones.
    Klugman V; Favus MJ
    Adv Endocrinol Metab; 1995; 6():117-42. PubMed ID: 7671093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis and clinical course of mixed calcium oxalate and uric acid nephrolithiasis.
    Millman S; Strauss AL; Parks JH; Coe FL
    Kidney Int; 1982 Oct; 22(4):366-70. PubMed ID: 7176335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of factors involved in calcium stone formation.
    Abraham PA; Smith CL
    Miner Electrolyte Metab; 1987; 13(3):201-8. PubMed ID: 3627051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Functional evaluation in patients with kidney calculi].
    Stojimirović B
    Srp Arh Celok Lek; 1998; 126(9-10):394-8. PubMed ID: 9863414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Asplin JR; Grynpas MD; Evan AP; Parker WR; Alexander KM; Coe FL
    Kidney Int; 2002 Mar; 61(3):975-87. PubMed ID: 11849452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal stone disease: Causes, evaluation and medical treatment.
    Heilberg IP; Schor N
    Arq Bras Endocrinol Metabol; 2006 Aug; 50(4):823-31. PubMed ID: 17117307
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.